Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
Aaron J. Roberto, Aileen Lorenzo, Kevin J. Li, et al.
Case Reports in Psychiatry (2016) Vol. 2016, pp. 1-4
Open Access | Times Cited: 21

Showing 21 citing articles:

Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 214
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 70
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems
William E. Fantegrossi, Catheryn D. Wilson, Michael D. Berquist
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 65-73
Open Access | Times Cited: 61
Psychosis and synthetic cannabinoids
Huiqiong Deng, Christopher D. Verrico, Thomas R. Kosten, et al.
Psychiatry Research (2018) Vol. 268, pp. 400-412
Closed Access | Times Cited: 61
The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review
Laura Orsolini, Stefania Chiappini, John Corkery, et al.
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 12, pp. 1253-1264
Open Access | Times Cited: 40
The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
Laura Orsolini, Stefania Chiappini, Duccio Papanti, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 38
Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review
Melissa Hobbs, Nicola J. Kalk, Paul D. Morrison, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 12, pp. 1289-1304
Open Access | Times Cited: 27
Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
Rajashekar Reddy Yeruva, Hema Madhuri Mekala, Meesha Sidhu, et al.
PubMed (2019) Vol. 16, Iss. 1-2, pp. 31-32
Closed Access | Times Cited: 24
Recurrent cannabis-induced catatonia: a case report and comprehensive systematic literature review
Reza Moshfeghinia, Mehrnaz Hosseinzadeh, Sara Mostafavi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis
Abigail C. Wright, Corinne Cather, Jodie Gilman, et al.
Child and Adolescent Psychiatric Clinics of North America (2019) Vol. 29, Iss. 1, pp. 145-156
Closed Access | Times Cited: 15
Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review
Raúl Felipe Palma-Álvarez, Albert Soriano-Día, Elena Ros-Cucurull, et al.
Journal of Dual Diagnosis (2021) Vol. 17, Iss. 2, pp. 159-171
Closed Access | Times Cited: 11
Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre
Hunter Robson, Rhiannon Braund, Michelle Glass, et al.
Clinical Toxicology (2020) Vol. 59, Iss. 6, pp. 472-479
Closed Access | Times Cited: 11
The Association Between Cannabinoids and Psychosis
Sai Krishna Tikka, Deepak Cyril D’Souza
Springer eBooks (2018), pp. 127-155
Closed Access | Times Cited: 10
Suicidal Ideation, Planning, and Attempts Among Synthetic Cannabinoid Users Across Different Demographic Subgroups
John M. Stogner, Courtney A. Patterson
Crisis (2021) Vol. 43, Iss. 4, pp. 323-330
Closed Access | Times Cited: 4
New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
Ahmed Alhassan, Srihari R. Prahad, Bradley G. Burk, et al.
PubMed (2024) Vol. 54, Iss. 1, pp. 33-39
Closed Access
The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice
Lucy R. Thomsen, Michelle Glass, Rhonda J. Rosengren
European Journal of Pharmacology (2024) Vol. 979, pp. 176844-176844
Open Access
Understanding aggressive behaviour in patients with schizophrenia through social cognitive theory: a narrative literature review
Samuel Ndoro
British Journal of Mental Health Nursing (2020) Vol. 9, Iss. 4, pp. 1-10
Closed Access | Times Cited: 3
Substance-Induced Psychosis: a Narrative Review
Lea Tomašić, Mirta Peček, Zrnka Kovačić Petrović
Current Addiction Reports (2023) Vol. 11, Iss. 1, pp. 55-67
Closed Access
Understanding the potential relationships between serious mental illness, substance use disorders and crime amongst psychiatric inpatients
M. Agius
(2018)
Closed Access
“Air fresheners” as legal highs
Marina Bježančević, Katarina Dodig‐Ćurković, Ružica Palić Kramarić
Croatian Medical Journal (2019) Vol. 60, Iss. 4, pp. 383-384
Open Access
Designer drugs
Gregory C. Janis
Elsevier eBooks (2020), pp. 269-276
Closed Access
Page 1

Scroll to top